Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility
Mariela Bollini1, José A Cisneros, Krasimir A Spasov
1Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA.
New non-nucleoside inhibitors of HIV-1 reverse transcriptase offer significantly improved solubility and maintain high antiviral activity. These compounds show potent efficacy against wild-type HIV-1 and key variants, addressing a critical need in HIV treatment.
Area of Science:
- Medicinal Chemistry
- Virology
- Drug Discovery
Background:
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are crucial for HIV-1 treatment.
- Existing NNRTIs like etravirine and rilpivirine face challenges with solubility.
- Improving solubility is key to enhancing drug delivery and efficacy.
Purpose of the Study:
- To develop novel NNRTIs with enhanced solubility and maintained high antiviral activity.
- To investigate the structure-activity relationship of modified NNRTIs.
- To identify potent NNRTI candidates against wild-type and variant HIV-1 strains.
Main Methods:
- Synthesis of novel NNRTI compounds with strategic modifications.
- Solubility testing of newly synthesized compounds.
- In vitro antiviral activity assays against HIV-1 (wild-type and variants).
- Structure-activity relationship analysis.
Main Results:
- Novel NNRTIs demonstrated approximately 100-fold greater solubility compared to etravirine and rilpivirine.
- The solubility enhancement was attributed to the introduction of a morpholinylalkoxy substituent.
- Compound 4d exhibited low-nanomolar antiviral activity against wild-type HIV-1 and key viral variants, comparable to etravirine.
- High antiviral potency was retained despite significant solubility improvements.
Conclusions:
- Strategic modification of NNRTI structure can lead to substantial solubility enhancements without compromising antiviral efficacy.
- The developed compounds represent promising candidates for improved HIV-1 therapy.
- Further development of these highly soluble NNRTIs could address limitations of current treatments.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
11:04Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
Published on: June 13, 2022
Related Concept Videos
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Basicity of Heterocyclic Aromatic Amines
Diazonium Group Substitution: –OH and –H
